Sensitivity of cognitive composite scores to amyloid accumulation in emergent Alzheimer's disease

Abstract

Background: In clinical trials for preclinical Alzheimer's disease (AD), cognition is the primary outcome and is measured by preclinical Alzheimer's disease cognitive composite (PACC) scores that combine data from neuropsychological tests of memory and executive function and clinical mental status.